| name | OnabotulinumtoxinA |
| brand names | | 1 | Botox | | 2 | Dysport | | 3 | Xeomin | | 4 | Jeuveau |
|
| classification | Neurotoxin, Botulinum Toxin Type A |
| pharmacokinetics | OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction. Its half-life varies by formulation and injection site. Primarily metabolized/eliminated by the liver. Systemic absorption is minimal; most remains localized. Specific pharmacokinetic data varies among preparations; consult product insert. |
| suggested dosage | Dosage varies greatly based on condition being treated. Consult a physician or qualified healthcare professional for appropriate dosage. Factors like patient age, weight, condition, and specific preparation determine the necessary dosage. |
| indications | | 1 | Chronic migraines | | 2 | Spasticity (e.g., cerebral palsy, multiple sclerosis) | | 3 | Hyperhidrosis (excessive sweating) | | 4 | Blepharospasm (involuntary eye closure) | | 5 | Strabismus (crossed eyes) | | 6 | Cervical dystonia (muscle spasms in the neck) | | 7 | Facial wrinkles (cosmetic use) | | 8 | Other conditions as determined by a physician |
|
| safety in pregnancy | Use only when clearly indicated and under direct medical supervision. Insufficient data to definitively assess risks. No significant negative effects shown during pregnancy, but risks/benefits must be carefully considered. Pregnant women should disclose any history of botulinum toxin A use. |
| safety in breastfeeding | Safety not well-established. Very low potential for significant systemic absorption, thus minimal risk to infant. Consult a healthcare provider for specific advice based on individual circumstances. |
| side effects | | 1 | Injection site reactions (e.g., pain, swelling, bruising, redness) | | 2 | Headache | | 3 | Muscle weakness | | 4 | Fatigue | | 5 | Dry mouth | | 6 | Dizziness | | 7 | Nausea | | 8 | Double vision (diplopia) | | 9 | Difficulty swallowing (dysphagia) | | 10 | Difficulty speaking (dysarthria) | | 11 | Flu-like symptoms | | 12 | Other rare side effects |
|
| alternatives | |
| contraindications | | 1 | Allergy to botulinum toxin or components | | 2 | Active infection/inflammation at injection site | | 3 | Known conditions where patient is at higher risk from temporary or prolonged muscle weakness | | 4 | Certain neurological conditions where contraindicated |
|
| interactions | Limited significant drug interactions documented. Concurrent use with other medications or therapies may influence outcomes; consult a physician. |
| warnings and precautions | Consult a physician to determine appropriateness and potential risks. Patients with certain neurological/muscular disorders should be carefully monitored. Duration of effectiveness may vary. |
| additional information | Wide range of medical/cosmetic uses; optimal use depends on individualized factors. Qualified healthcare professional should determine appropriate use and dosage. |
| patient specific info | |
